According to a new study, cervical cancer diagnoses and deaths in the UK are expected to rise sharply among women over the age of 50 over the next two decades, although the death from illness among vaccinated young adults may be almost eradicated.
A study published in The Lancet Public Health shows that by 2040, the likely situation in England may be 75% less than the current vaccination of young women. Cervical cancer deaths under the age of 17 will virtually disappear when the project is implemented in 2008.
But for older women who have never been vaccinated against human papillomavirus (HPV), there are still problems that cause the majority of cervical cancers. About 60% of women are infected with HPV at some point. Most clearly from their system, but for women who have had HPV before, the vaccine is not good.
It is estimated that the diagnosis and death in the 50-64 age group will increase. Epidemiologists at Queen Mary University in London say the number of cases will rise 62%. This may increase the death toll from 183 in 2015 to 449 in 2040.
Queen Alejandra Castanon, PhD, said: “The main reason is the aging population, women aged 25-40 currently will not benefit from vaccination – and they are at a very high age of HPV infection.” Mary, one of the authors .
Sexual intercourse in the 25- to 40-year-old age group, especially with multiple partners, puts them at greater risk of contracting sexually transmitted viruses. “Unfortunately, there is an increased risk of getting HPV infection to cancer from unvaccinated individuals born after 1960, suggesting that current screening coverage is not enough to sustain – less reduction over the next 20 years – cervical cancer Incidence, “paper.
Even among women who have not been vaccinated, cervical cancer may now be considered as non-threatening. Older women are more likely to feel safe, especially if they have a long-term partner. As a result, fewer women will be screened – but infection takes at least 10 years to cause cancer.
The study, funded by Jo’s Cervical Cancer Trust, the author and charity, said more needs to be done to improve the screening rate – and a more accurate screening method – the detection of HPV infection – requires more than planned In 2019.
Robert Music, chief executive of the trust, said: “This research should be a wake-up call for action, and declining cervical screening attendance rates will kill people at all ages and may not happen. As older women are aging and risky, it is important to explore changes in programs that reduce this risk, including increasing screening age from 64 to self-testing.
Nicolas Wentzensen and Mark Schiffman at the National Cancer Institute said in an editorial in the journal that women under the age of 30 in developing countries are vaccinated against HPV. This can help improve herd immunity by reducing the amount of circulating virus in the community.